## FCX: Freeport-McMoRan, Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 1.4% below STRENGTH zone (3.0-6.0%); PEG 2.98 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($39.97)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. Freeport-McMoRan Inc. $FCX Shares Purchased by Schroder Investment Management Group**
- Source: MarketBeat | 20251201T121333 | Bullish | Relevance: 99%
- Schroder Investment Management Group increased its stake in Freeport-McMoRan Inc. (NYSE:FCX) by 14.2% in the second quarter, acquiring an additional 272,955 shares. This purchase brings their total ownership to 2,193,216 shares, valued at approximately $95.08 million, representing about 0.15% of the company. Freeport-McMoRan recently reported strong quarterly earnings, beating analyst estimates with an EPS of $0.50 and revenue of $6.97 billion, and maintains a consensus "Buy" rating with a target price of $46.73.

**2. Shareholders that lost money on Freeport-McMoRan Inc.(FCX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More**
- Source: Your Wyoming Link | 20251201T132255 | Neutral | Relevance: 99%
- The Gross Law Firm is urging shareholders of Freeport-McMoRan Inc. (NYSE: FCX) who lost money investing in the company between February 15, 2022, and September 24, 2025, to join a class action lawsuit. The lawsuit alleges that Freeport-McMoRan made misleading statements and failed to disclose safety issues at its Grasberg Block Cave mine in Indonesia, leading to heightened regulatory, litigation, and reputational risks. Shareholders are encouraged to register by the January 12, 2026 deadline to potentially be appointed as lead plaintiff.

**3. Arrowstreet Capital Limited Partnership Sells 1,825,504 Shares of Freeport-McMoRan Inc. $FCX**
- Source: MarketBeat | 20251202T083619 | Bullish | Relevance: 99%
- Arrowstreet Capital Limited Partnership reduced its stake in Freeport-McMoRan Inc. by 15% in Q2 2025, selling 1,825,504 shares and retaining 10,372,036 shares valued at $449.6 million. Freeport-McMoRan reported strong Q3 earnings, exceeding analyst expectations with EPS of $0.50 and revenue of $6.97 billion, and maintains a "Buy" consensus rating with a $46.73 target price from analysts. The company also declared a quarterly dividend of $0.15 per share.

**4. Freeport-McMoRan Inc. (FCX) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before January 12, 2026**
- Source: WLNS 6 News | 20251201T104400 | Neutral | Relevance: 99%
- Investors in Freeport-McMoRan Inc. (FCX) are being urged to contact Levi & Korsinsky LLP before January 12, 2026, regarding a potential securities class action lawsuit. The lawsuit alleges that Freeport-McMoRan made false statements and concealed inadequate safety measures at its Grasberg Block Cave mine in Indonesia, leading to a heightened risk for workers and undisclosed regulatory, litigation, and reputational risks. Shareholders who suffered losses between February 15, 2022, and September 24, 2025, are encouraged to learn about their rights to seek recovery.

**5. Deadline Alert: Freeport-McMoran Inc. (FCX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit**
- Source: MyHighPlains.com | 20251201T120000 | Neutral | Relevance: 99%
- Glancy Prongay & Murray LLP reminds investors of Freeport-McMoran Inc. (FCX) about an upcoming January 12, 2026 deadline to file a lead plaintiff motion in a securities fraud class action lawsuit. The lawsuit alleges that Freeport-McMoran Inc. made misleading statements and failed to disclose critical information regarding safety at its Grasberg Block Cave mine in Indonesia, leading to significant stock price drops following incidents involving trapped and fatally injured workers. Shareholders who suffered losses during the Class Period (February 15, 2022, and September 24, 2025) are urged to contact the law firm to learn more about pursuing claims.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | JP Morgan | $58 | $50 | +16% |
| 2025-11-19 | Morgan Stanley | $44 | $46 | -4% |
| 2025-11-19 | BMO Capital | $47 | $48 | -2% |
| 2025-11-19 | Scotiabank | $47 | $51 | -8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-11-19 | Morgan Stanley | main | Overweight |
| 2025-11-19 | BMO Capital | main | Outperform |
| 2025-11-19 | Scotiabank | up | Sector Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.05M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 3.0x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +1.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.98 signals overvaluation risk, limited margin of safety. Forward P/E 20.2x attractive for 40% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment negative (3 target cuts vs 1 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $66.7B |
| Beta | 1.48 |
| 52W Range | $27.66 - $49.12 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.98 |
| Forward P/E | 20.2 |
| Current P/E | 28.3 |
| YoY Growth | 39.9% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from 0.2% to 1.4% (+1.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.6pp (needs >3.0% for momentum thesis). MRS_5 at 0.6% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 59.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.37% (CS: 81) | Neutral |
| RSI_14 | 58.8 | Neutral |
| MACD Histogram | 0.37 | Bullish |
| vs SMA20 | 1.054x | Above |
| vs SMA50 | 1.055x | Above |
| vs SMA200 | 1.063x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $42.97
- **Stop Loss:** $39.97 (7.0% risk)
- **Target:** $45.97 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 333
- **Position Value:** $14,309.01
- **Portfolio %:** 14.31%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*